EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed point-of-care business, announces that the Board has confirmed a cash dividend of 1.1p per ordinary share which will be paid on 1 December 2021.
The dividend timetable dates are below:
Ex-dividend date: | 4 November 2021 |
Record date: | 5 November 2021 |
Payment date: | 1 December 2021 |
For further information please contact:
EKF Diagnostics Holdings plc | www.ekfdiagnostics.com | ||
Christopher Mills, Non-executive Chairman | Tel: +44 (0)29 2071 0570 | ||
Mike Salter, CEO | |||
Richard Evans, FD & COO | |||
Singer Capital Markets (Nominated Adviser & Joint Broker) | Tel: +44 (0)20 7496 3000 | ||
Aubrey Powell / George Tzimas / Tom Salvesen | |||
Investec Bank plc (Joint Broker) | Tel: +44 (0)20 7597 4000 | ||
Gary Clarence / Daniel Adams | |||
Walbrook PR Limited | Tel: +44 (0)20 7933 8780 or | ||
Paul McManus / Lianne Cawthorne | Mob: +44 (0)7980 541 893 / +44 (0)7584 391 303 |
Attachments
- Original document
- Permalink
Disclaimer
EKF Diagnostics Holdings plc published this content on 25 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 October 2021 08:25:04 UTC.